Compare RGEN & FLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | FLS |
|---|---|---|
| Founded | 1981 | 1790 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 6.8B |
| IPO Year | N/A | N/A |
| Metric | RGEN | FLS |
|---|---|---|
| Price | $163.80 | $73.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | ★ $170.90 | $75.50 |
| AVG Volume (30 Days) | 778.3K | ★ 1.4M |
| Earning Date | 10-28-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 1.14% |
| EPS Growth | N/A | ★ 69.42 |
| EPS | 0.03 | ★ 3.44 |
| Revenue | $707,890,000.00 | ★ $4,687,417,000.00 |
| Revenue This Year | $17.84 | $5.80 |
| Revenue Next Year | $12.57 | $4.04 |
| P/E Ratio | $6,437.16 | ★ $21.36 |
| Revenue Growth | ★ 11.74 | 3.19 |
| 52 Week Low | $102.97 | $37.34 |
| 52 Week High | $182.52 | $73.80 |
| Indicator | RGEN | FLS |
|---|---|---|
| Relative Strength Index (RSI) | 54.87 | 69.16 |
| Support Level | $160.11 | $70.90 |
| Resistance Level | $170.40 | $72.82 |
| Average True Range (ATR) | 5.38 | 1.90 |
| MACD | -0.85 | -0.09 |
| Stochastic Oscillator | 44.68 | 96.59 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.